Press releases
- Press releases
- Browse
Press releases
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
Sales of the mucolytic Mucodyne grow after Beacon successfully negotiates reimbursement in the UK. More
Chronic obstructive pulmonary disease (COPD), a respiratory disease commonly known as chronic bronchitis or emphysema, is the fourth leading cause of death worldwide, but a University of Western Ontario researcher is providing new insight into the disease More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
Zambon and APR have recently signed a Strategic Alliance and License Agreement for the further development and marketing of innovative patented consumer oriented products in patch form. More
Agreement to generate in excess of £25 million in milestones and development funding More
Zambon and Fournier signed a license agreement for the development of new chemical entities from Fournier's know-how and patents on Interleukin-4 (IL-4) antagonists and Interleukin-4/Interleukin-5 (IL-4/IL-5) secretion inhibitors More
Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade More
CCL Pharmaceuticals, the independent specialist contract aerosol developer and manufacturer, completes respiratory mdi development projects for two major European clients More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 22 pages - $500
Sep 2010 - 27 pages - $2,000
Mar 2011 - 28 pages - $500
Nov 2010 - 178 pages - $1,495
May 2011 - 15 pages - $250
Sep 2009 - 394 pages - $4,000
Jun 2009 - $15,200
Jun 2010 - 210 pages - $2,500
Nov 2010 - 160 pages - $1,495
Dec 2010 - 29 pages - $1,000
Your selection
- Therapeutic target
- Respiratory del
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Adult respiratory distress syndrome
- Allergy, respiratory
- Asthma
- Asthma, bronchospasm
- Bronchitis
- Chest disorder (other)
- Chlamydia pneumoniae
- Chronic obstructive pulmonary disease
- Cough
- Cystic fibrosis
- Dysplasia, bronchopulmonary
- Emphysema
- Granulomatous lung disease sarcoidosis
- Idiopathic respiratory distress syndrome
- Meconium aspiration syndrome
- Nasal disorder (other)
- Obstructive airway disease
- Pneumonia
- Pneumonocystis carinii lung infection
- Pseudomonas lung infection
- Respiratory disorder (other)
- Respiratory syncytial virus
- Respiratory tract infections
- Rhinitis
- Rhinovirus (common cold)
- Sinusitis
- Sleep apnea
- Throat disorder (other)
- Tuberculosis
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us